|
Experience and Background
James J. Marino, the managing partner of the Princeton office, is chair of the corporate and securities life science group. With more than 25 years of experience, Mr. Marino focuses his practice on representing public and privately held life sciences companies, including biotechnology, medical device, healthcare, and pharmaceuticals, in the full range of corporate, transactional and finance matters.
Recognized by leading legal directory Chambers USA as a "leading light" in the life sciences industry for his work in the corporate and securities field, Mr. Marino regularly represents numerous life sciences companies in ongoing corporate compliance and governance matters. He also counsels boards of directors and special committees of life sciences companies on issues ranging from fiduciary duties, conflict of interest and compliance procedures to executive compensation and evaluation and interested party transactions.
Mr. Marino has extensive experience advising life sciences companies in public offerings and private placements of equity, including IPOs and follow-on offerings, PIPEs, early and later-state venture capital financings. In addition, he has structured and negotiated innovative strategic alliances, mergers and acquisitions, divestitures, spin-offs, and joint ventures for numerous life sciences companies.
In 1994, Mr. Marino was one of the founders of the BIONJ, a New Jersey-based trade association of biotechnology companies, and has represented BIONJ since that date.
Professional Activities
Mr. Marino served as a member of former Governor Kean's Task Force on Capital for New Technologies, former Governor Florio's Task Force on Financing Strategies for New Jersey and the Capital Sources Committee of Prosperity New Jersey. He served as Chair of the Board of Trustees of Middlesex County College. He was also a trustee and treasurer of Robert Wood Johnson University Hospital and a former member of the New Jersey State Board of Higher Education. Mr. Marino served for over a decade as a member of the Board of Directors of Pharmacopeia Drug Discovery, Inc.
Education
Rutgers University, B.A., magna cum laude, 1972; M.B.A., 1976
Rutgers University School of Law, Newark, J.D., 1979, member (1977-79) and project editor (1978-79) of the Rutgers Law Review
Publications and Lectures
|
